-
Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-05-08 Sandhya Subash, Dilip K. Singh, Deepak Ahire, S. Cyrus Khojasteh, Bernard P. Murray, Michael A. Zientek, Robert S. Jones, Priyanka Kulkarni, Faizan Zubair, Bill J. Smith, Scott Heyward, J. Steven Leeder, Bhagwat Prasad
-
Redox-Sensitive Poly(lactic-co-glycolic acid) Nanoparticles of Palbociclib: Development, Ultrasound/Photoacoustic Imaging, and Smart Breast Cancer Therapy Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-05-05 Piyush Dhamija, Abhishesh Kumar Mehata, Rupen Tamang, Jyoti Bonlawar, Vaishali, Ankit Kumar Malik, Aseem Setia, Shailendra Kumar, Ranadheer Reddy Challa, Biplob Koch, Madaswamy S. Muthu
-
Highlighting the Contributions of the Editorial Advisory Board to Molecular Pharmaceutics Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-05-06 Lynne S. Taylor
-
Rationalizing Counterion Selection for the Development of Lipophilic Salts: A Case Study with Venetoclax Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-05-04 Callum D. Ryan, Brendan T. Griffin, Joseph P. O’Shea
-
Exploring Bimetallic Nanoparticles in Alzheimer’s Therapy: A Novel Bio-Assisted Synthesis with Multitarget Potential Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-05-02 Gülcihan Gülseren, Zeynep Demirsoy, Merve Şeker, O..̈mer Büyükünal
-
Treg-Derived Extracellular Vesicles: Roles in Diseases and Theranostics Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-05-02 Tingting Wu, Lulu Wang, Chen Gao, Chen Jian, Yajing Liu, Zhiwen Fu, Chen Shi
-
Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002 Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-05-01 Tullio V. F. Esposito, Colin Blackadar, Lan Wu, Cristina Rodríguez-Rodríguez, Evan F. Haney, Daniel Pletzer, Katayoun Saatchi, Robert E. W. Hancock, Urs O. Häfeli
-
In Vitro Release from Polymeric Core/Shell Nanoparticles through the Lens of Multiscale Modeling Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-30 Tommaso Casalini, Kevin Treacher, Iain Grant, Mariagrazia Marucci
-
Application of Epithelial Growth Factor Receptor-Targeted Magnetic Resonance Imaging and Near-Infrared II Dual-Modal Probe in Lung Cancer Diagnosis and Surgical Resection Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-30 Chao Li, Changjian Li, Jian Zhou, Yueqi Wang, Hainan Wu, Luzheng Xu, Yifeng Li, Xizhao Sui, Guanchao Jiang, Yun Li, Zhenhua Hu, Jie Tian, Fan Yang
-
Synthon Approach in Crystal Engineering to Modulate Physicochemical Properties in Organic Salts of Chlorpropamide Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-30 Anila M. Menon, Nagamalli Naga Sidhartha, Ipsha Shruti, Ajay Suresh, Ravindra Meena, Amol G. Dikundwar, Deepak Chopra
-
Liposomal Copermeation Assay Reveals Unexpected Membrane Interactions of Commonly Prescribed Drugs Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-29 Klára Odehnalová, Martin Balouch, Kateřina Storchmannová, Eliška Petrová, Magdalena Konefał, Aleš Zadražil, Karel Berka, Jiří Brus, František Štěpánek
-
Probing the Molecular and Macroscopic Structure of Solid Solutions by Dynamic Nuclear Polarization (DNP) Enhanced 13C and 15N Solid-State NMR Spectroscopy Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-29 Jiashan Mi, Yunhua Chen, Benjamin A. Atterberry, Fredrik L. Nordstrom, David A. Hirsh, Aaron J. Rossini
-
Albumin-Binding Lutetium-177-Labeled LLP2A Derivatives as Theranostics for Melanoma Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-29 Michael D. Pun, Fabio Gallazzi, Khanh-Van Ho, Lisa Watkinson, Terry L. Carmack, Ejike Iweha, Longbo Li, Carolyn J. Anderson
-
Folic Acid-Decorated Nanocrystals as Highly Loaded Trojan Horses to Target Cancer Cells Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-27 Marta G. Fuster, Jiawen Wang, Octavio Fandiño, Gloria Víllora, Alejandro J. Paredes
-
STING-Targeted PET Imaging for Specific Detection and Therapeutic Monitoring of Myocarditis Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-26 Zhou Ye, Xin Lu, Manman Zhu, Lei Bi, Fan Yang, Bin Zhou, Duo Xu, Lan Yao
-
Mechanochemically Induced Solid-State Transformations of Levofloxacin Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-25 Lena Kadri, Maria Carta, Giulio Lampronti, Francesco Delogu, Lidia Tajber
-
Quality by Design Considerations for Drop-on-Demand Point-of-Care Pharmaceutical Manufacturing of Precision Medicine Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-25 Thomas P. Forbes, John Greg Gillen, William Feeney, Johnny Ho
-
Correction to “Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing” Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-25 Chaeho Moon, Sawittree Sahakijpijarn, Esther Y. Maier, David R. Taft, Miguel O. Jara, Tuangrat Praphawatvet, Rachana Manandhar, Nivedita Shetty, Joseph Lubach, Ajit Narang, Karthik Nagapudi, Robert O. Williams, III
In this manuscript, the authors stated: “While GDC-0214 has only minimal oral bioavailability,16 Dengler et al. reported that inhaled GDC-0214 can reduce lung pathology, without affecting systemic JAK1 activity in rodents.17” Upon further review of the manuscript postpublication, the authors have identified an error in this statement within the Introduction section. The accurate statement should read:
-
Combining Scattering Experiments and Colloid Theory to Characterize Charge Effects in Concentrated Antibody Solutions Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-25 Alessandro Gulotta, Marco Polimeni, Samuel Lenton, Charles G. Starr, Anna Stradner, Emanuela Zaccarelli, Peter Schurtenberger
-
Nanocarrier-Integrated Microneedles: Divulging the Potential of Novel Frontiers for Fostering the Management of Skin Ailments Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-25 Pooja Khairnar, Vivek Phatale, Shalini Shukla, Akeemat O. Tijani, Aachal Hedaoo, Jordan Strauss, Gabrielle Verana, Ganesh Vambhurkar, Ashana Puri, Saurabh Srivastava
-
Integrative Salt Selection and Formulation Optimization: Perspectives of Disproportionation and Microenvironmental pH Modulation Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-24 Shikhar Mohan, Yi Li, Kevin Chu, Liliana De La Paz, Diana Sperger, Bing Shi, Chris Foti, Victor Rucker, Chiajen Lai
-
Preparation of Liposome Gel by Calcium Cross-Linking Induces the Long-Term Release of DOX to Improve the Antitumor Effect Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-22 Long Wang, Yi Wang, Zixuan Ye, Yitong Yu, Cheng Wang, Lin Qiu, Xuancheng Du, Shuwen Zhou, Jianhao Wang, Pengju Jiang
-
Understanding the Roles of Excipients in Moisture Management in Solid Dosage Forms Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-22 Natalia Veronica, Paul W. S. Heng, Celine V. Liew
-
Repurposing of Antifungal Drug Flucytosine/Flucytosine Cocrystals for Anticancer Activity against Prostate Cancer Targeting Apoptosis and Inflammatory Signaling Pathways Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-22 Manimurugan Kanagavel, Rajan Marystella Sparjan Samuvel, Vaikundamoorthy Ramalingam, Sunil Kumar Nechipadappu
-
Tuning the Physical State of Aripiprazole by Mesoporous Silica Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-21 Daniel Kramarczyk, Justyna Knapik-Kowalczuk, Joanna Klimontko, Mateusz Kurek, Renata Jachowicz, Marian Paluch
-
Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-19 Niloufar Salehi, Jozef Al-Gousous, Bart Hens, Gordon L. Amidon, Robert M. Ziff, Gregory E. Amidon
-
Macrophages and Natural Killers Degrade α-Synuclein Aggregates Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-18 Mikhail Matveyenka, Kiryl Zhaliazka, Dmitry Kurouski
-
Recent Progress of Small Interfering RNA Delivery on the Market and Clinical Stage Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-17 Fan Guo, Yan Li, Wenjun Yu, Yuanlei Fu, Jing Zhang, Haiqiang Cao
-
Voices in Molecular Pharmaceutics: Meet Professor Keisuke Ueda, Who Scrutinizes the Molecular-Level Properties of Drugs and Formulations Using NMR Spectroscopy Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-17 Keisuke Ueda
-
Customizable Porphyrin Platform Enables Folate Receptor PET Imaging Using Copper-64 Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-16 Hailey A. Houson, Zhiyuan Wu, Phuong-Lien Doan Cao, Jonathan S. Lindsey, Suzanne E. Lapi
-
Feasibility Study of Single-Photon Emission Computed Tomography with Iodine-123 Labeled Metaiodobenzylguanidine for Preclinical Evaluation of Labetalol as a β-Adrenergic Receptor Blocker Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-16 Yiseul Choi, Eun Sang Lee, Sang-Keun Woo, Kyo Chul Lee, Hye Kyung Chung, Joo Hyun Kang
-
Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood–Brain Barrier Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-16 Andrew L. Zhou, Suresh K. Swaminathan, Vrishali S. Salian, Lushan Wang, Geoffry L. Curran, Hoon-Ki Min, Val J. Lowe, Karunya K. Kandimalla
-
Transfer of ANS-Like Drugs from Micellar Drug Delivery Systems to Albumin Is Highly Favorable and Protected from Competition with Surfactant by “Reserved” Binding Sites Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-16 Iulia Carabadjac, Leonie C. Vormittag, Thomas Muszer, Jakob Wuth, Maximilian H. Ulbrich, Heiko Heerklotz
-
Lipids Extracted from Mycobacterial Membrane and Enveloped PLGA Nanoparticles for Encapsulating Antibacterial Drugs Elicit Synergistic Antimicrobial Response against Mycobacteria Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-15 Xueyu Pu, Yuanyuan Wang, Xi Wang, Xiaoqing Sang, Miaomiao Jiang, DaWei Qi, Xin Zhao, Rong Chen, Jianwei Li, Xiang Liu, Zhidong Liu, Jian Yang
-
Blue-Light-Activated Water-Soluble Sn(IV)-Porphyrins for Antibacterial Photodynamic Therapy (aPDT) against Drug-Resistant Bacterial Pathogens Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-15 T. Nagarajan, M. P. Gayathri, John Mack, Tebello Nyokong, Sutharsan Govindarajan, Balaji Babu
-
Phospholipid Type Regulates Protein Corona Composition and In Vivo Performance of Lipid Nanodiscs Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-12 Feng Pan, Mengyuan Liu, Guanghui Li, Boqian Chen, Yuxiu Chu, Yang Yang, Ercan Wu, Yifei Yu, Shiqi Lin, Tianhao Ding, Xiaoli Wei, Changyou Zhan, Jun Qian
-
Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4 Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-12 Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
-
Design, Synthesis, and Evaluation of [18F]BIBD-300 as a Positron Emission Tomography Tracer for Poly(ADP-Ribose) Polymerase-1 Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-12 Wei Zheng, Yong Huang, Yi Xie, Tingyu Yang, Xuebo Cheng, Hualong Chen, Chengze Li, Zeng Jiang, Ziyue Yu, Zhongjing Li, Lu Zhang, Leilei Yuan, Yajing Liu, Ying Liang, Zehui Wu
-
Transdermal Delivery of Pramipexole Using Microneedle Technology for the Potential Treatment of Parkinson’s Disease Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-11 Mary B. McGuckin, Aaron R.J. Hutton, Ellie R. Davis, Akmal H.B. Sabri, Anastasia Ripolin, Achmad Himawan, Yara A. Naser, Rand Ghanma, Brett Greer, Helen O. McCarthy, Alejandro J. Paredes, Eneko Larrañeta, Ryan F. Donnelly
-
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-10 Claire Mackie, Sumit Arora, Paul Seo, Rebecca Moody, Bhagwant Rege, Xavier Pepin, Tycho Heimbach, Christer Tannergren, Amitava Mitra, Sandra Suarez-Sharp, Luiza Novaes Borges, Shinichi Kijima, Evangelos Kotzagiorgis, Maria Malamatari, Shereeni Veerasingham, James E. Polli, Gregory Rullo
-
Enhanced Theranostic Efficacy of 89Zr and 177Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-08 Zhao Chen, Qi Yang, Lele Song, Yongkang Qiu, Tianyao Wang, Sitong Wu, Wenpeng Huang, Xinyao Sun, Aixiang Wang, Lei Kang
-
The Effect of Lipid Composition on the Liposomal Delivery of Camptothecin Developed by Active Click Loading Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-05 Lei Xie, Qian Zhang, Qian Zhu, Yang Wang, Shuijiao Niu, Xinyue Zhang, Yuting Huang, Jiayao Li, Xiaoxue Liu, Zhiyuan Xue, Xia Zhao, Yaxin Zheng
-
Quantifying the Lymphatic Transport of Model Therapeutics from the Brain in Rats Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-05 Thu A Hoang, Gracia Gracia, Enyuan Cao, Joseph A Nicolazzo, Natalie L Trevaskis
-
Concentration-Dependent Diffusion of Monoclonal Antibodies: Underlying Mechanisms of Anomalous Diffusion Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-04 Gaurav Kumar, Arezoo M. Ardekani
-
Synthesis and Evaluation of Radiogallium Labeled Bone-Imaging Probes Using Oligo-γ-Carboxy Glutamic Acid Peptides as Carriers to Bone Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-04 Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Nurmaya Effendi, Takeshi Fuchigami, Masayuki Munekane, Hiroshi Wakabayashi, Seigo Kinuya
-
Role for Carboxylic Acid Moiety in NSAIDs: Favoring the Binding at Site II of Bovine Serum Albumin Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-04 Luiza de Carvalho Bertozo, Hugo Cesar Tadeu, Anila Sebastian, Martyna Maszota-Zieleniak, Sergey A. Samsonov, Valdecir Farias Ximenes
-
In Vitro Simulation of the Fasted Gastric Conditions and Their Variability to Elucidate Contrasting Properties of the Marketed Dabigatran Etexilate Pellet-Filled Capsules and Loose Pellets Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-03 Marcela Staniszewska, Daria Myslitska, Michał Romański, Sebastian Polak, Grzegorz Garbacz, Justyna Dobosz, Michał Smoleński, Jadwiga Paszkowska, Dorota Danielak
-
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-04-01 Maria Larkina, Ruslan Varvashenya, Feruza Yuldasheva, Evgenii Plotnikov, Ekaterina Bezverkhniaia, Maria Tretyakova, Roman Zelchan, Alexey Schulga, Elena Konovalova, Anzhelika Vorobyeva, Mikhail Belousov, Anna Orlova, Vladimir Tolmachev, Sergey Deyev
-
Synthesis and Evaluation of [18F]AlF-NOTA-c-DVAP: A Novel PET Probe for Imaging GRP78 in Cancer Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-30 Jiawen Huang, Lu Bai, Dazhi Shi, Wenhao Jiang, Pan Chen, Ye Dong, Xiaojun Zhang, Jiangling Peng, Jinqiang Hou, Yujing Lu, Xiaohong Huang, Ganghua Tang, Shun Huang
-
A Model Study to Assess Fibrillation and Product Stability to Support Peptide Drug Design Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-29 Harshil K. Renawala, Karthik B. Chandrababu, Katelyn J. Smith, Suzanne M. D’Addio, Elizabeth M. Topp
-
Characterization of Pediatric Rectal Absorption, Drug Disposition, and Sedation Level for Midazolam Gel Using Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-29 Jinying Zhu, Sufeng Zhou, Lu Wang, Yuqing Zhao, Jie Wang, Tangping Zhao, Tongtong Li, Feng Shao
-
Investigation of Optimum Production Conditions and the Stability of β-Cyclodextrin–Perfluorocarbon Nanocone Clusters for Histotripsy Applications Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-29 Waleed Mustafa, Sarah Hall, Laura Huynh, Rachel Mannasse, Serter Luleburgaz, Eli Vlaisavljevich, Yasemin Yuksel Durmaz
-
Dual Functionality of Poloxamer 188 in Freeze-Dried Protein Formulations: A Stabilizer in Frozen Solutions and a Bulking Agent in Lyophiles Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-29 Jinghan Li, Bhushan Munjal, Chaowang Zeng, Raj Suryanarayanan
-
Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-28 Meijiao Song, Lei Zhu, Lumeng Zhang, Xiaoguang Ge, Jinfeng Cao, Yong Teng, Rui Tian
-
Potentiation of Brain Bioavailability Using Thermoreversible Cubosomal Formulation Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-28 Harshvardhan Jain, Bala Prabhakar, Pravin K. Shende
-
Combination Nano-Delivery Systems Remodel the Immunosuppressive Tumor Microenvironment for Metastatic Triple-Negative Breast Cancer Therapy Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-27 Liya Bai, Hui Liu, Ran You, Xiaoyu Jiang, Tao Zhang, Yunan Li, Tianhe Shan, Zhanyin Qian, Yinsong Wang, Yuanyuan Liu, Chunyu Li
-
Correction to “PET Imaging of Peptide Probe Al[18F]F-NOTA-PCP1 for Monitoring the Engagement of PD-L1 Antibodies in Tumors” Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-26 Yang Zhang, Yong Wang, Yunhao Chen, Xingchen Ding, Shijie Wang, Wei Liu, Zhiguo Liu, Man Hu
We have adjusted the sequence of authors to Yang Zhang,† Yong Wang,† Yunhao Chen, Xingchen Ding, Shijie Wang, Wei Liu, Zhiguo Liu,* and Man Hu*. This change is reflected in the authorship of this Correction. This article has not yet been cited by other publications.
-
Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse Model Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-26 Baron J. Bechtold, Katherine D. Lynch, Victoria O. Oyanna, M. Ridge Call, Tyler N. Graf, Nicholas H. Oberlies, John D. Clarke
-
Voices in Molecular Pharmaceutics: Meet Professor Owen S. Fenton, Designer of Lipid Nanoparticles for Messenger RNA Delivery Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-25 Owen S. Fenton
-
Preparation of Compound Salvia miltiorrhiza–Blumea balsamifera Nanoemulsion Gel and Its Effect on Hypertrophic Scars in the Rabbit Ear Model Mol. Pharmaceutics (IF 4.9) Pub Date : 2024-03-25 Teng Chen, Zuhua Wang, Xingchu Gong, Jiaojiao Zhang, Ning Zhang, Jing Yang, Yue Zhu, Ying Zhou